Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease

Gastroenterology

Volumn 123, Issue 3, 2002, Pages 679-688

  Abreu, Maria T ^a   Taylor, Kent D ^b   Lin, Ying Chao ^b   Hang, Tieu ^b   Gaiennie, Joanne ^a   Landers, Carol J ^a   Vasiliauskas, Eric A ^a   Kam, Lori Y ^a   Rojany, Micha ^a   Papadakis, Konstantinos A ^a   Rotter, Jerome I ^b   Targan, Stephan R ^a   Yang, Huiying ^b  

^a Inflammatory Bowel Disease Center   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0036725827     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.35393     Document Type: Article

References (50)

1. A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998
2. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics
3. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup
4. Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: A study in IBD families
5. Frequency of glucocorticoid resistance and dependency in Crohn's disease
6. The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
7. ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease
8. Probiotics and inflammatory bowel diseases
9. Varying cecal bacterial loads influence colitis and gastritis in HLA-B27 transgenic rats
10. Bacterial regulation of intestinal immune responses
11. Microbe-host interactions in the alimentary tract: The gateway to understanding inflammatory bowel disease
12. Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice
13. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
14. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex: Transfer from cd14 to tlr4 and md-2
15. The interleukin-1 receptor/Toll-like receptor superfamily: Signal generators for pro-inflammatory interleukins and microbial products
16. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes
17. Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B
18. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipo-polysaccharide
19. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB
20. Human Nod1 confers responsiveness to bacterial lipopolysaccharides
21. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
22. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
23. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations
24. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease
25. CARD15 mutations in Blau syndrome
26. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope
27. Identification of a novel mycobacterial his tone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease
28. Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA
29. Specific antibody response to oligomannosidic epitopes in Crohn's disease
30. The molecular classification of the clinical manifestations of Crohn's disease
31. Perforating and non-perforating indications for repeated operations in Crohn's disease: Evidence for two clinical forms
32. Allelic discrimination using fluorogenic probes and the 5′-nuclease assay
33. Oligonucleotides with conjugated dihydropyrroloindole tripeptides: Base composition and backbone effects on hybridization
34. 3′-Minor groove binder-DNA probes increase specificity at PCR extension temperatures
35. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease
36. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: Ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis
37. Comparative study of ASCA (anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease
38. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease
39. Risk factors for early postoperative recurrence of Crohn's disease
40. Surgical recurrence of perforating and nonperforating Crohn's disease. A study of 101 surgically treated patients
41. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease
42. Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: Cellular mediators and animal models
43. Can we influence fibrosis in Crohn's disease?
44. Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts
45. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease
46. Magnitude of anti-Saccharomyces cerevisiae antibody (ASCA) expression is linked in Crohn's disease families to the major histocompatibility complex (MHC) region
47. Granulomatous infections: Etiology and classification
48. Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease